Issue 7, 2025

Design of an anti-PD-L1-mediated MOF nanodrug delivery system using terpyridine-metal coordination for tumor theranostics

Abstract

An anti-PD-L1 mediated nanodrug delivery system is developed by modifying the MOF surface and using Tpy-Gd3+-Tpy coordination chemistry, enabling the simultaneous delivery of chemotherapy and immunotherapy drugs. The platform enables regulated drug release and integrates multiple imaging modalities, promoting targeted delivery and facilitating tumor diagnosis through FL and MR imaging.

Graphical abstract: Design of an anti-PD-L1-mediated MOF nanodrug delivery system using terpyridine-metal coordination for tumor theranostics

Supplementary files

Article information

Article type
Communication
Submitted
06 Nov 2024
Accepted
13 Dec 2024
First published
23 Dec 2024

Chem. Commun., 2025,61, 1407-1410

Design of an anti-PD-L1-mediated MOF nanodrug delivery system using terpyridine-metal coordination for tumor theranostics

X. Han, J. Chen, Z. Cheng and S. Zhou, Chem. Commun., 2025, 61, 1407 DOI: 10.1039/D4CC05933F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements